000 01532 a2200457 4500
005 20250517204151.0
264 0 _c20181011
008 201810s 0 0 eng d
022 _a1432-1041
024 7 _a10.1007/s00228-018-2437-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKokki, Hannu
245 0 0 _aHow do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patients.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cJun 2018
300 _a785-792 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdrenergic beta-1 Receptor Antagonists
_xblood
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiological Availability
650 0 4 _aCoronary Artery Bypass
650 0 4 _aExtracorporeal Circulation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMetoprolol
_xblood
650 0 4 _aMiddle Aged
700 1 _aMaaroos, Martin
700 1 _aEllam, Sten
700 1 _aHalonen, Jari
700 1 _aOjanperä, Ilkka
700 1 _aRanta, Merja
700 1 _aRanta, Veli-Pekka
700 1 _aTolonen, Aleksandra
700 1 _aLindberg, Oscar
700 1 _aViitala, Matias
700 1 _aHartikainen, Juha
773 0 _tEuropean journal of clinical pharmacology
_gvol. 74
_gno. 6
_gp. 785-792
856 4 0 _uhttps://doi.org/10.1007/s00228-018-2437-1
_zAvailable from publisher's website
999 _c28164080
_d28164080